Wird geladen...
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
Five days following the 3rd cycle of nivolumab, a monoclonal antibody, which acts as immune checkpoint inhibitor against the programmed cell death protein-1, for metastatic lung adenocarcinoma, a 56-year-old woman presented at the hospital critically ill. On admission, she had severe diabetic ketoac...
Gespeichert in:
| Veröffentlicht in: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bioscientifica Ltd
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863245/ https://ncbi.nlm.nih.gov/pubmed/29576870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-18-0111 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|